Nigel Gibben said: "The Prevention Zone means anyone who keeps poultry such as chickens, ducks and geese, even as pets, must take action to stop them coming into contact with wild birds to protect them from avian flu.
"Birds should be moved into a suitable building, or if that isn’t possible owners must take sensible precautions to keep them away from wild birds, like putting up netting to create a temporary enclosure and keeping food and water supplies inside where they cannot be contaminated by wild birds.
"Even when birds are kept indoors a risk of infection remains so keepers must also practice good biosecurity, for example by disinfecting footwear and equipment and washing clothing after contact with birds.
"Recent H5N8 avian flu findings in wild birds and a backyard flock in Wales highlight just how essential it is to minimise contact between wild and captive birds and maintain good biosecurity to reduce the risk of infection.
"We must continue to be vigilant and do all we can to protect against this highly pathogenic strain of the disease, which is why we are extending the Prevention Zone, have introduced a ban on poultry gatherings and continue to strengthen surveillance to understand the extent of infection in wild birds."
Ian (pictured right) qualified from Glasgow University and has a master’s degree in veterinary parasitology. He is head of ESCCAP - the European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland, guideline director for ESCCAP Europe and editorial board member for Companion Animal. and VetCPD Journal. He is also a practising vet and co-owner of The Mount Veterinary Practice in Fleetwood, Lancashire.
Lockdown has seen a rise in the numbers of dogs and cats in the UK, including imported pets. Horiba says some of these are coming in via the official route, which includes preventative measures to reduce health risks. However, many are moved outside of UK regulations and some will become ill in the days or even months after they arrive. Ian will explain how timely, accurate testing will help detect the threat to these animals.
Lisa Martin from Horiba said: "I hope that as many veterinary surgeons, nurses, students and support staff as possible will join us for our Educational Premiere! We are looking forward to this first webinar in our veterinary CPD series, with expert Ian Wright highlighting the best ways to keep pets and people safe. Join us on 1st July at 7.30pm to hear more and to ask Ian your questions on this very topical subject. Dress code: casual."
To register, visit: https://attendee.gotowebinar.com/register/5429203015286962191
Annual renewal fees for veterinary surgeons will remain at the same level as in 2021: £364 for UK-practising members, £182 for members practising outside the UK and £60 for non-practising members.
The removal of the alternative fee payment arrangements means there will no longer be the option to pay in instalments and the fee needs to be paid in full by the usual deadline of 1 April.
RCVS Treasurer Niall Connell said: “We understand that many veterinary surgeons and veterinary nurses will have been impacted financially over the last couple of years, and we appreciate that this has been a very difficult time for the professions.
"We are pleased that we are able to keep fees static for a second year running, whilst maintaining a strong programme of strategic projects that help to set, uphold and advance standards within the professions.”
Topics covered will include practical applications of enrichment for zoo species, options for reproductive control in pet ferrets, challenges of exotics out-of-hours care, veterinary care of invertebrates and decision-making in wildlife cases.
The Association says that this year, there will be a greater focus on masterclasses, practical sessions and roundtable discussions, and that there will be plenty of new research, case reports, case series and the most recent advancements in the field of zoo, wildlife and exotic animal medicine.
There will be dedicated streams covering zoo health, nursing, exotic pets and wildlife health, together with a stream for students and new graduates.
The social programme includes the student-mentor mixer, a wine and canapés evening, a gala dinner and silent disco.
Registration fees have been held at the same level as 2019: tickets for non-members range from £410 for one day, to £760 for all three; members get a discount.
www.bvzs.co.uk
The research is being carried out by James Glass MRCVS (pictured), a PhD researcher working in the Suicide Behaviour Research Lab at the University of Glasgow, supervised by Professor Rory O'Connor - current president of the International Association for Suicide Prevention.
To take part, vets and student vets are being asked to complete a 15-25 minute survey, which must be done in one sitting.
Survey answers are strictly confidential.
Everyone is invited to participate, regardless of whether or not you have experienced suicidal thoughts, however James cautions that some of the questions may be upsetting for anyone currently experiencing suicidal feelings, and emphasises that participants are free to withdraw from the study at any point by closing the webpage, whereupon any answers already submitted with be discarded.
The study is open until 31st December 2024.
https://tinyurl.com/StudyTeamVet
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
Reference
The study, Urinary incontinence in bitches under primary veterinary care in England: prevalence and risk factors, which will be published in the Journal of Small Animal Practice, also found that other factors such as weight, neuter status and age also play key roles.
The authors hope that the study findings will provide an evidence base that allows veterinary surgeons to enhance their clinical recommendations for higher risk bitches.
The study was based on a population of 100,397 bitches attending 119 veterinary clinics across England. The main findings included:
The study also gave evidence on the welfare impact from urinary incontinence. Almost half of cases (45.6%) received medical therapy for the condition. In addition, of the bitches that died during the study period, urinary incontinence was recorded as either contributory or the main reason for death in 16.7 % of these deaths.
RVC veterinary epidemiologist and VetCompass researcher Dr Dan O’Neill said: "This urinary incontinence study has uncovered dramatic breed predispositions that have previously been hidden to vets and owners.
"Overall, about 3% of bitches were affected but this rose to over 30% in the Irish Setter and over 20% in the Dobermann with many other breeds also predisposed.
"Vets can now use these results to alert owners to typical clinical signs in order to ensure earlier treatment and better outcomes. The study also suggests increased risk in heavier and neutered bitches.
"Following on from this study, a VetCompass Masters project supported by BSAVA PetSavers is working to unravel these associations in order to identify potential preventive strategies, especially in those highly predisposed breeds."
The paper is available in Early View on Wiley Online Library ahead of publication in the JSAP at http://onlinelibrary.wiley.com/doi/10.1111/jsap.12731/full
Photo: ©Diane Peace Collection / The Kennel Club
Canine Arthritis Management says the service is designed to help address issues with the traditional veterinary care approach, such as short consult times, significant workplace pressure and lack of understanding of the caregiver.
The service offers expert consultations through which veterinary professionals and other caregivers can confer with a dedicated team of experts in canine arthritis for the latest insights and treatment strategies.
The telehealth service can also supplement the veterinary consultation, giving extra time to create personalised care plans for clients, tailored to their dog's specific needs.
Canine Arthritis Management says its care plans are designed with a holistic approach, considering not only the medical requirements of the dog but also its living environment and lifestyle.
Canine Arthritis Telehealth also offers ongoing support and educational resources.
Canine Arthritis Management Founder, Hannah Capon MRCVS said: “One of the biggest misunderstandings surrounding osteoarthritis is that it is simple to manage.
"It is not.
"The long term, waxing and waning nature of the disease, combined with the financial and physical commitments, leads to emotional exhaustion for the caregiver.
"Combining this with a lack of understanding of the disease, confusion regarding the myriad of ways to address it, and anxiety surrounding the future, caregivers of animals with chronic disease need more support, and that is exactly what this service offers.”
caninearthritisteleguidance.co.uk
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical
Boehringer Ingelheim Vetmedica has launched a competition to find 12 dogs that have responded well to treatment with Vetmedin, to feature in the company's forthcoming 2012 Better Dogs calendar.
Boehringer is particularly interested in hearing about dogs with funny or quirky stories, or ones that have made a dramatic heart-warming recovery. If the submission makes it to the short list of 12 they will be featured in Vetmedin's 2012 Better Dogs Calendar which will be available to veterinary practices later in the year. In addition, the vet with the best story will win a £250 Red Letter Days' voucher with the 11 runners up winning the new BSAVA Manual of Thoracic Imaging.
In return for pet owners agreeing to their dog's story being submitted, Boehringer will send each veterinary practice a complimentary pack of either Vetmedin 1.25mg x 50 tablets or Vetmedin 5.0mg x 50 tablets, depending on the normal prescription, to give to their client.
Entries can be made either on the 2012 Better Dogs Calendar form which can be found in a recent Vetmedin mailing or via email to vetmedin.bra@boehringer-ingelheim.com. All entries should be accompanied by a photograph. Terms and conditions apply and the closing date for submissions is 30 September 2011.
For further information, please contact your Boehringer Ingelheim Vetmedica Territory Manager or call 01344 746959.
Ceva Animal Health has announced that it is now accepting nominations for its annual Animal Welfare Awards.
The awards recognise veterinary surgeons, veterinary nurses and charity professionals who go the extra mile to prevent and reduce welfare problems for animals.
If you think one of your colleagues, vet or nurse, should be recognised for their work improving animal welfare, you'll need to nominate them before the 15th February 2013 deadline.
The awards include:
Winners of all awards will have a choice of luxury prize - ranging from spa weekends, European city breaks, countryside retreats or an animal experience. All individuals who nominate will be automatically entered into a prize draw to win £250 of high street vouchers. Ginette Bryant from Ceva, said: "The Ceva Animal Welfare Awards are an opportunity to recognise the hard work and dedication of individuals in the veterinary and animal charity industry. Our mission 'Together, beyond animal health', recognises that the health of animals, humans and the planet are inextricably linked, these awards are fitting way to work towards improving the health of all. "Whether it is improving animal welfare through client education in practice, championing good causes or helping specific cases, we know there are many people who share our ambitions in preventing and reducing companion animal welfare issues. It is these passionate individuals who are the unsung heroes of our industry and we're really excited to hear the inspiring stories from each nomination."
There are also three awards for people who work outside the veterinary or animal charity sector.
Nominations forms are available from www.ceva.com.
The deadline for entries is 15 February 2013.
For further details or additional nomination forms for your practice call Ceva on 01494 781 510 or email welfare.awards@ceva.com The awards ceremony will be held on Wednesday 3 April 2013 during the BSAVA conference in Birmingham.
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
CVS says the use of ear cytology in OE is beneficial, both as a diagnostic and to evaluate the response to therapy.
However, in 2019 the company looked at 26,269 of its patients and found that ear cytology was only being used in 19.2% of cases, in line with the rest of the profession.
Only 11% of cases were being provided with in-house point-of-care cytology, whilst 8.2% had it performed externally.
80.8% of patients with OE were being prescribed antibiotics without cytological support, with 5% of these the highest priority critically important antibiotics (HPCIAs).
This low level of cytology use in primary care was suspected to be a major contributory factor to the significant use of unnecessary antibiotics.
To support its practices, CVS first looked at the barriers to performing ear cytology interventions, which were identified as a lack of confidence in using the microscope (particularly focusing on x100 and identification of pathological events), a perceived lack of time, insufficient or poorly working equipment, a lack of access to equipment, and the perception that cytology does not change the treatment choice or outcome.
As a second step, a minimal list of cytology equipment was developed to ensure that all sites had the right kit.
New equipment was then supplied to a practice if it did not meet minimum standards.
The company then produced education and resource materials, including new guidelines, imagery and video guides, to upskill both its vets and nurses.
The training focused on: equipment maintenance, cleaning and troubleshooting, how to use the microscope – including x100 magnification and the slide oil immersion technique, how to identify pathological changes, and time management to get a consultation done – including swabbing, microscope analysis, diagnosis and client consultation.
Each site was then provided with its own data, so that it could monitor progress.
Elizabeth McLennan Green, CVS Clinical Director for the North, said: “One of our goals with this project was to minimise the number of antibiotics prescribed without associated diagnostics, and to use ear cytology to guide therapy and response to treatment for the benefit of our patients and clients.”
“We know that low ear cytology interventions are an issue across the profession. We wanted to do better. So ear cytology has been our first and longest running clinical improvement project.
"We’re thrilled with the brilliant results our colleagues are now achieving.”
There's a video presentation about the project here: https://vimeo.com/875515008/bdc3ee5920
Photo: Emily Spencer, Head Vet at Castle Vets
The randomised controlled trial1 was conducted in 11 flocks with 6840 lambs during last year's lambing season (2023-2024), making it the largest ever navel protection study in the UK.
For the trial, odd numbered lambs were treated with strong iodine and even numbered lambs were treated with NoBACZ Navel.
Current practices on the farm were observed, so if the farmer normally dipped the lambs’ umbilicus they dipped with iodine or NoBACZ Navel and if they normally sprayed the umbilicus then they sprayed with iodine or NoBACZ Navel.
Survival and weights were recorded.
The study concluded that NoBACZ Navel demonstrated superior protection compared to iodine, with a 21% reduction in mortality (p=0.005).
On top of that, lambs that had NoBACZ Navel applied to the umbilicus and tagging sites were on average 230g heavier than those in the iodine group at eight weeks.
Fiona said: "Until now, best practice to manage navel ill has been to apply strong iodine to the umbilicus and ear-tagging sites by dipping or spraying to desiccate the umbilicus and disinfect the surface.
"Prophylactic antibiotic use also still occurs on as many as 19% of farms2, which is not best practice or good antimicrobial stewardship.
“NoBACZ Navel provides greater desiccation of the umbilicus than iodine and forms a non-colonisable waterproof barrier which protects lambs from the environment.
“The economic and welfare benefits to farmers are clear, with 17 more lambs alive per 1,000 born and an average of 230g extra bodyweight per lamb at eight weeks, which more than justifies the 16p per dose investment in NoBACZ Navel.
"During the trial I also received fantastic feedback from farmers on its ease of use and long-lasting protection to these vulnerable sites.”
www.nobacz.com
References
Pfizer Animal Health has confirmed that the agreement to acquire multiple product franchises from the Schering-Plough Corporation has been completed - and approved by the European Commission. Pfizer has acquired these assets for approximately euro 116 million in cash.
The agreement covers all European Union countries and the franchises include all major animal health species including cattle, swine, equine and companion animal. Pfizer executives say the agreement leaves them with the most in-depth coverage of therapeutic areas, and the most highly recognised brands, in the industry. Precise details of the agreement are not being released although additional information on the products concerned will be the subject of further announcements in due course.
Pfizer has acquired certain rights to the following products in the European Economic Area:
Albert Bourla, President of Pfizer Animal Health in Europe, said: "This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners. Pfizer spends hundreds of millions of dollars on research and development every year, and brings more new products to market than any other company, but when the opportunity arose to add well known, well respected brands to a portfolio that is already extremely strong, we had little hesitation in taking it."
Ceva Animal Health has launched a new TV advertising campaign to raise awareness of the benefits of the veterinary behavioural product, Feliway.
The new advertisement, features the new 'Feliway' purple cat playing happily in the home with its family.
The advertisement will appear on the major UK channels including More 4, E4, ITV 1, Sky Channels and the Discovery Channel for one week from 16th September 2013, with an additional three weeks coverage during October 2013. Behind the scenes' footage of the filming of the advertisement can also be viewed on the Feliway YouTube Channel: http://www.youtube.com/channel/UCtAXd5mReYc6JGufxRirvng?feature=watch
A Feliway video on demand and YouTube campaign will be available to viewers between 16th September 2013 and 21st October 2013 and will be repeated between 15th November 2013 and 2nd December 2013.
An Adaptil video on demand campaign will be aired between 21st October 2013 and 11th November 2013 to raise awareness of Adaptil in the run up to and during the firework season. The video on demand will be available across ITV player, Sky Anytime On Demand, 4oD and YouTube.
For more information, call 01494 781510 or contact your local Ceva territory manager.
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Virbac Animal Health has launched an extra small version of its VeggieDent dental chews for dogs weighing less than 5kg.
Research commissioned by the company shows that 9% of all dogs in the UK weigh less than 5kg1 and that periodontal disease is over-represented in this group2.
According to the Kennel Club, celebrity culture is boosting the popularity of small breeds. Apparently there was a 25% increase in Kennel Club registrations of Chihuahuas in 2011, following publicity about Paris Hilton and her Chihuahua. Virbac says numbers of other small miniature breeds such as pugs are also growing rapidly.
Virbac says VeggieDent chews are designed to work with the animal's chewing action, 100% vegetable, highly palatable and feature a special design to increase chewing time. A recent study3 showed that a daily XS VeggieDent reduced halitosis as well as significantly reducing gingivitis, plaque, and tartar accumulation.
Chris Geddes MRCVS, Product Manager at Virbac said: "With growing numbers of very small dogs in the UK, we wanted to produce a chew which was exactly the right size for them.
VeggieDent Chews are already popular among dog owners because they are a nutritious and palatable plaque control aid, minimising tartar build up and improving breath odour. With the launch of the extra small size, we now offer the perfect chew for every size of dog."
For further information, contact your Territory Manager or call Head Office on 01359 243243.
References:
Dan (MRCVS) & Kirsty (RVN) Forster, the husband and wife team behind Isle of Wight-based The Mobile Vet are celebrating a Queen's Award for Enterprise.
The Mobile Vet offers a mobile service in custom-designed vehicles and also has a fully-equipped surgery based in Newport where further consultations, operations and diagnostics can be performed, giving clients the option to choose between a home visit or a more traditional form of veterinary care for their pets.
News of the award landed on their doormat recently, in a letter saying: "I am delighted to inform you that Her Majesty The Queen has been graciously pleased to approve the Prime Minister's recommendation that your organisation should receive a Queen's Award for Enterprise in Innovation this year."
The Queen announced the winners of the awards as part of her 90th birthday celebrations yesterday, and Kirsty & Dan have been invited to Buckingham Palace to meet her at an official reception in July.
Dan said: "We have been fortunate enough to receive excellent feedback from our clients since starting our business & enjoy an immense amount of job satisfaction with the way we work. A nod from Her Majesty is truly the crowning glory for our business. It just goes to show what can be achieved with exceptional hard work and effort, the love & support of family/friends & a formidable staff. This award is for all these people that help to make our business great!
"We are very much looking forward to meeting the Queen and can't quite get our heads round it. Kirsty has spent hours looking for a dress and I am brushing up on my royal etiquette!"
The company says the workshop will provide vets with an opportunity to extend their knowledge of Q Fever, a zoonotic disease that not only affects reproductive performance and productivity in cattle but also presents a health threat to farmers, farming families and related professions such as vets, veterinary technicians and abattoir workers.
The workshop will be presented by Raphaël Guatteo (pictured right), Professor in Bovine Medicine and Health Management at the Veterinary College of Nantes (Oniris) in France.
Raphaël will share his wealth of knowledge on Q Fever including his extensive research into the disease.
He'll answer any questions that delegates may have about Q Fever and will discuss case studies, diagnostic challenges and the importance of quick diagnosis, treatment options and prevention through vaccination.
The Q Fever workshop will take place between 4.00pm and 5.30pm on Thursday 20 October in the Shorthorn Room at the Hilton Metropole in Birmingham.
The workshop is free of charge, but spaces are limited.
The findings of a Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, have demonstrated the efficacy of Advantix in repelling ticks and sandflies, thus reducing the risk of potentially deadly diseases.
The study, conducted over two years by a team headed by Professor Domenico Otranto of the Faculty of Veterinary Medicine (Universitá degli Studi di Bari) Italy, with diagnostic support from a team led by Dr. Edward Breitschwerdt at the North Carolina State University, USA, found that dogs treated regularly with Advantix spot-on had a greater than 90% reduction in CVBD cases, including a 100% reduction in new cases of potentially deadly leishmaniosis and a 94.6% decrease in ehrlichiosis.
The study also found that Advantix provided 97.9% protection against tick infestation, compared to untreated dogs, where 100% were infested at the peak of the season. The level of protection offered by Advantix was apparently all the more notable because of particularly large numbers of ticks and sand flies and high prevalence of associated diseases like leishmaniosis or babesiosis in the area of the study.
Prof. Otranto said: "Our study shows the importance of protecting dogs with an effective treatment that repels as well as kills parasites like ticks and sand flies. Despite the high challenge faced by the dogs in our study, nearly all our treated dogs remained free from ticks throughout most of the study, and more than 90% remained free from CVBDs for the whole study time.
"Because we included naïve sentinel beagles in the study, we were also able to model what would happen to dogs travelling to areas where CVBDs are present. We found that by the end of the study, only the Advantix-treated beagles remained protected from infection, while 80% of the untreated beagles were infected with a CVBD. This demonstrates the very real need to protect dogs that are travelling to endemic areas."
According to Bayer, the study showed some interesting results with dogs that were positive with CVBDs when they entered the study. Of these, half of those treated with Advantix were negative for CVBDs at the end of treatment, compared with only 13% of untreated dogs. This suggests the potential for natural clearance of CVBDs if a repellent treatment is used to prevent new transmissions.
Bayer says the study was extremely comprehensive, studying both indigenous and introduced naïve puppies, monitoring for several CVBDs and working with Dr. Breitschwerdt's team in the USA to use highly sensitive molecular testing techniques to ensure optimal diagnostic accuracy. Dr. Breitschwerdt said: "This is the most comprehensive study, to my knowledge, ever conducted testing the efficacy of a repellent ectoparasiticide to prevent the transmission of a spectrum of CVBDs in young dogs."
Leading parasitologist Dr. Luis Cardoso of the University of Trás-os-Montes e Alto Douro, Portugal said: "Thanks to this study we can see just how effective a treatment that repels as well as kills can be."
Europe's largest private specialist veterinary practice, Davies Veterinary Specialists, has opened a new centre at the premises of the Hyde Park Veterinary Centre in Connaught St., London W2.
Davies Veterinary Specialists employs 40 veterinary surgeons, 23 of them RCVS Recognised Specialists and more than 50 nurses. The main hospital, based in Bedfordshire, has sophisticated diagnostic, surgical and treatment facilities and offers integrated multi-disciplinary care.
Clive Elwood, Managing Director of DVS, said: "We believe that pet owners should have easy access to the top veterinary specialists in the country. We are now bringing a team of specialists offering consultations in medicine, cardiology, ultrasonography, neurology, ophthalmology, orthopaedic and soft tissue surgery to Davies London. This will make it much easier for London vets to offer their clients a convenient referral service, with full access to state-of-the-art facilities."
The Hyde Park Veterinary Centre is a long-established central London veterinary clinic. Recently expanded and refurbished, the clinic has invested heavily in the latest diagnostic and treatment facilities for the clinical care and treatment of London's pets. Head vet Andrew Prentis said: "We are all very excited about the collaboration with Davies: this new local access to top level specialists is really going to help London's vets offer their clients the very best in veterinary care at all times."
For more information, call 0207 535 0444 or visit www.vetspecialists.co.uk/london
Vetoquinol has published a waiting room poster which highlights canine pain, to support Cimalgex.
Robert Simpson, Product Manager for Cimalgex said: "This poster aims to highlight that pain may not be obvious to pet owners and that signs which the owner may believe to be age related, for example stiffness, may actually be behavioural signs of pain. The most common sign of pain is a change in behaviour and so this is an area which we believe needs to be highlighted to the pet owner1.
"This new poster uses a strong image to catch the pet owner's attention which, when combined with its simple message, will prompt the pet owner to ask for further information from the veterinary practice regarding pain to ensure the overall wellbeing of their pet. This poster complements our client leaflet in helping the veterinary practice to assist the pet owner to spot signs of pain which may not be very obvious."
To find out more or to request a waiting room poster for your practice please contact your Vetoquinol Territory Manager or call 01280 825424.
1. Hellyer P. et al. AAHA/AAFP Pain Management guidelines for Dogs and Cats. J. AM Anim Hosp Assoc 2007; 43: 235-248.
Three veterinary surgeons and an appointed RCVS Councillor have been awarded an OBE in the Queen's Birthday Honours.
Caroline Freedman, who has been appointed to Council from the University of Edinburgh since 2005, received a British Empire Medal for services to animal welfare in Edinburgh. Caroline will be officially retiring from Council at RCVS Day on Friday 11 July but will remain as a lay member of the Practice Standards Group - the coordinating body for the Practice Standards Scheme.
Three veterinary surgeons were also awarded OBEs in the Queen's Birthday Honours. Sarah Cleaveland, Professor of Comparative Epidemiology at the University of Glasgow, was honoured for her contribution to veterinary epidemiology. Robert Houston, former Chief Veterinary Officer for Northern Ireland, was recognised for services to veterinary science in the country and Professor Julie Fitzpatrick, the Scientific Director of the Moredun Research Institute and Chief Executive of the Moredun Foundation, was honoured for services to animal health and science.
RCVS President Colonel Neil Smith said: "I am delighted to see these very deserving people from the veterinary world receive their due recognition in this year's Birthday Honours.
"During her time on Council Caroline has provided a greatly valued lay perspective on the veterinary issues of the day and I am pleased that she will continue to give her valuable insight to the organisation through the Practice Standards Group.
"Professor Cleaveland is our guest speaker at this year's RCVS Day where she will be speaking about her vital work in tackling zoonotic diseases on an international basis, so I am delighted to see that her contribution to human and animal health is being recognised.
"In addition, Bert Houston and Professor Fitzpatrick have contributed a great deal to both the veterinary profession and animal welfare in UK, with the latter being a member of our former Research Subcommittee."
Compassion Understood, a new company set up to provide veterinary staff with training in how to help clients deal with pet loss, and provide owners with a new information resource on the subject, launched at BSAVA this week.
The new service has been set up partly in response to a survey which showed a disparity between what veterinary professionals think clients need in relation to euthanasia and what they actually want.
The research1 showed that 60% of owners felt their vet handled the euthanasia of their pet very well, leaving 40% who had a clear desire for veterinary staff to understand more, to help prepare them better for their loss, and to signpost where they can access more support if required.
Compassion Understood Managing Director Douglas Muir said: "Our research showed that 70% of veterinary professionals felt that further training in supporting clients through pet loss would be beneficial, and only 35% of vets felt well-equipped to answer questions from pet owners about the right time to say goodbye.
"This, coupled with a very clear need for more support expressed by the owners in our surveys, led me to see that there was a double need: more training was needed in end-of-life for the practice team, on communication as well as clinical aspects of end-of-life; also some kind of resource was needed for pet owners, so they could access clear and helpful information.
"There are some very good support sites out there, but the information is quite fragmented and not easy to find. We wanted to pull everything together in one place and from there we could signpost them to where to get further help if needed. And so Compassion Understood was born, to help veterinary practices, and pet owners."
The new Compassion Understood Pet Loss Support Training programme has been put together with the help of end-of-life and hospice vet Dr Susan Gregersen. She said: "Speaking to colleagues in the many practices we collaborate with, I’ve learned just how many feel inadequately prepared. They’re unhappy that they’re short of time – and sometimes skills – to do a good job when an often-distraught client needs them most. But if a client is left with bad memories at the end of life, they may not return to the same practice with another pet; as we know, about 1 in 5 do not¹."
The programme includes modules covering the clinical aspects of assessing quality of life, decision-making around end-of-life, pre-euthanasia preparation, and palliative and animal hospice care. Other aspects covered are the emotional and psychological aspects of losing a pet, as well as how to protect the practice team from compassion fatigue or emotional depletion.
The training programme is fully online, and can be completed at the learner’s own pace. The learning approaches and delivery have been overseen by educational expert, Dr Jenny Moffett previously of the University of Surrey, herself a veterinarian with a keen interest in communication and pet loss support.
Susan said: "Vet school training on end of life and euthanasia is still sparse, as many vets will agree. I see the online course as being about learning to care rather than to cure, giving vets the confidence and skill to show real compassion while remaining professional."
Pet Loss Survey, 2015. Compassion Understood. Data on file.